Emicizumab

CAS No. 1610943-06-0

Emicizumab( —— )

Catalog No. M36904 CAS No. 1610943-06-0

Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 3010 Get Quote
5MG 3952 Get Quote
10MG 5339 Get Quote
25MG 7691 Get Quote
50MG 10304 Get Quote
100MG 13680 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Emicizumab
  • Note
    Research use only, not for human use.
  • Brief Description
    Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
  • Description
    Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research.
  • In Vitro
    ——
  • In Vivo
    Animal Model:FVIII-deficient mice Dosage:1.5-10 mg/kg Administration:IV, 24 hours before tail-clip bleeding was performed Result:Significantly reduced blood loss in a tail-clip-bleeding model using FVIII-deficient mice.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1610943-06-0
  • Formula Weight
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ferrière S, et al. A hemophilia A mouse model for the in vivo assessment of emicizumab function. Blood. 2020 Aug 6;136(6):740-748.?
molnova catalog
related products
  • Isoxepac

    Isoxepac is a non-steroidal anti-antiphlogistic agent and analgesic.

  • Benin

    Benin is an effective cytostatic drug used for the treatment of generalized carcinoma of the breast.

  • Retro 2

    Retro 2 is a plant toxin ricin ?inhibitor, itprotects HeLa cells against Ricin, Stx1 and Stx2, selectively blocks retrograde toxin trafficking at the early endosome-TGN (trans-Golgi network) interface.